Rose is a managing editor at The American Journal of Managed Care® (AJMC®).
She has a BA in journalism & media studies and Spanish from Rutgers University. You can connect with Rose on LinkedIn.
Stem Cells Highlighted as Potential Therapeutic Option in Huntington Disease
October 15th 2022Although no pharmacological treatment offers long-term efficacy or extends survival with Huntington disease at this point, research suggests that stem-cell therapy holds promise in this and other neurodegenerative diseases.
Read More
Review Underscores Potential and Obstacles of Universal CAR T-Cell Therapy
October 15th 2022Despite the obstacles and risks, the review authors conclude that universal chimeric antigen receptor (CAR) T-cell therapy has the potential to play a key role and mitigate some of the limitations associated with autologous CAR T-cell therapy in cancer treatment.
Read More
Patients With Lower-Risk MF, Low- or High-Risk ET Report Significant QOL Impacts
October 12th 2022Despite the use of therapies to address the clinical manifestations of myelofibrosis (MF) and essential thrombocythemia (ET), the symptom burdens of these conditions continue to negatively affect patient quality of life (QOL).
Read More
CAR T-Cell Therapy Outcomes Are Not Impacted by Baseline Renal Function, Study Finds
September 30th 2022Renal outcomes and chimeric antigen receptor (CAR) T-cell therapy efficacy were unaffected by baseline renal status in a cohort of patients with diffuse large B cell lymphoma, but acute kidney injury during treatment was associated with worse clinical outcomes.
Read More
Study Supports Comprehensive Genomic Profiling for Patients With Biliary Tract Cancer
September 24th 2022A small study suggests that comprehensive genomic profiling can help with clinical decision-making and predicting clinical outcomes in advanced biliary tract cancer, but further research is needed.
Read More
Case Report Describes Youngest Recorded Patient With Intrahepatic Sarcomatoid Cholangiocarcinoma
September 24th 2022The rare condition can easily be confused with hepatocellular carcinoma, but immunohistochemical studies can help accurately diagnose intrahepatic sarcomatoid cholangiocarcinoma.
Read More
Review Highlights Advances in SCD Treatment, Potential Targets for Novel Agents
September 17th 2022The review discusses hydroxyurea and 3 additional drugs approved by the FDA—L-glutamine, crizanlizumab, and voxelotor—as well as agents currently being investigated to treat sickle cell disease (SCD).
Read More
ICER Releases Draft Evidence Report on Gene Therapies for Hemophilia A and B
September 17th 2022Despite $2.5 million placeholder price tags, the Institute for Clinical and Economic Review draft evidence report considers gene therapy cost-effective versus comparators in both hemophilia A and B.
Read More